← Alle mensen

LD

Lieming Ding

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor-Positive and ERBB2-Negative Gevorderd Breast Cancer Afte...
JAMA oncology · 1 september 2025
Vorolanib plus everolimus versus everolimus bij mRCC: fase III
European journal of cancer (Oxford, England : 1990) · 2023-01
Standaard versus hoge-dosis icotinib bij EGFR-gemuteerd NSCLC
Clinical cancer research : an official journal of the American Association for Cancer Research · 1 juli 2020